How Much Nicotinamide Riboside Is Right for a 70 lb Senior Dog?

By Patricia Perkins, DVM, CVA, CVCH, CAC, BHS

✓ Medically reviewed by Patricia Perkins, DVM, CVA, CVCH, CAC, BHS — August 31, 2026 For general education — not a substitute for veterinary care.

Longevity · September 4, 2026 · 6 min read

There is no approved per-pound NR dose for dogs — only label ranges, one small trial, and a lot of marketing ahead of the data.

Before you measure out a chew for a 70 lb dog, know this: nobody has run a dose-ranging NR trial in dogs of that size. Every label number you’ll see — mine included in spirit, not brand — is an extrapolation from human and rodent data, dressed up to look more settled than it is.

Here’s the checklist I actually use when an owner brings in a 65–75 lb senior and asks about nicotinamide riboside:

• Match the label tier to body weight, not to the marketing copy. Most NASC-audited NR products scale by weight band (small, medium, large), and a 70 lb dog usually lands in the top or second-highest tier — follow the product’s printed range, not a number you saw in a forum.
• Confirm the actual NR dose per serving, in milligrams, before comparing products. Formulas vary widely; some brands blend NR with quercetin or resveratrol at doses too low to matter on their own.
• Ask what the whole-body picture looks like before adding anything. Cellular energy support means little if a dog is stiff, guarded through the hips, or reluctant on stairs for orthopedic reasons a chew can’t touch.
• Expect a rebuild timeline of weeks, not days. NAD+ precursors work at the mitochondrial level; owners chasing overnight change from a supplement are usually chasing the wrong signal.
• Reassess with your veterinarian at 4–6 weeks, using objective markers — gait, stair tolerance, sleep quality — rather than impression alone.

Now the reasoning behind each of those.

The dosing math nobody has actually run in dogs

Human NR trials have pushed doses as high as 2,000 mg daily without significant adverse events, and repeated-dose animal toxicology work in rats and dogs established a no-observed-adverse-effect level around 300 mg/kg body weight per day — figures reviewed in the EFSA Journal safety assessment of nicotinamide riboside chloride as a novel food ingredient. That NOAEL sounds reassuring, but it describes the point below which no harm was observed in a toxicology study — it is not a target dose, and it says nothing about what amount actually supports healthy aging in a 70 lb dog’s daily life. Translating a rodent-and-human safety ceiling into a practical chew dose is an extrapolation, not a validated protocol, and any brand implying otherwise is overstating what the science supports.

What I tell owners instead: pick a NASC-audited product, verify the milligram dose printed on the label, and follow the weight-tier instructions exactly. Do not double a dose because a dog seems “extra tired” — that instinct treats a supplement like a drug with a therapeutic window, and NR isn’t dosed that way in the current evidence base.

A whole-body exam comes before a supplement decision

I build my recommendation from the musculoskeletal exam outward, not from the ingredient panel inward. A supplement conversation that skips the hands-on exam is starting in the wrong place.

Consider a 70 lb, 10-year-old Labrador mix I evaluated after the owner asked about NAD+ chews for “slowing down.” On exam, she had reduced extension through both hips and mild epaxial muscle guarding along the lumbar spine — findings that predate any cellular-aging conversation. By day 10 of a structured mobility plan (weight management, joint-appropriate exercise, and a veterinary recheck), her stride length had visibly improved before a single NR chew entered the picture. The lesson isn’t that supplements don’t matter; it’s that a supplement layered onto an unaddressed orthopedic issue will underperform, and owners deserve to know that before they spend money assuming the chew is doing all the work. This is a composite scenario built to illustrate the exam-first sequence, not a documented case outcome.

Where the antioxidant pairings help — and where they don’t

Quercetin and resveratrol are commonly stacked with NR in longevity formulas, and it’s worth being precise about what each has actually shown. Quercetin is a flavonoid studied for antioxidant and cellular-support properties, but a 2024 in vitro study testing quercetin at various concentrations found it did not affect feeding behavior in the model organism tested — a reminder that promising antioxidant activity in a dish doesn’t automatically translate into a measurable in-dog benefit, a distinction covered in Pharmaceuticals. Resveratrol shows a similarly mixed picture: one 2026 study found that embryonic exposure to a moderate resveratrol concentration accelerated development but shortened adult lifespan in the model tested, published in Phytomedicine — evidence that “more antioxidant” is not automatically “more longevity,” even in simple organisms, let alone in a 70 lb dog.

The more encouraging canine-specific data point comes from a randomized, controlled trial testing a senolytic-and-NAD+-precursor combination in senior dogs, which reported improved owner-assessed cognitive function relative to placebo, published in Scientific Reports. That trial is genuinely useful — it’s one of the few canine RCTs in this space — but it tested a specific combination product at a specific protocol, not nicotinamide riboside alone, and one trial does not establish a dose-response curve for a 70 lb dog on a different formula. If you’re weighing whether an NR chew is even appropriate for a dog with a cancer diagnosis, that’s a separate, higher-stakes conversation worth reading up on before you start — see our piece on whether nicotinamide riboside is safe for a dog with cancer.

A failed shortcut worth naming

Not every owner follows the label, and the mismatch usually shows up the same way. A client with a 72 lb senior shepherd mix once split a large-dog dose across morning and evening meals, assuming twice-daily dosing at half strength would be gentler than the labeled once-daily amount. Three weeks in, there was no change in the dog’s energy or coat, and the owner had also, without realizing it, been crushing the chew into food — a habit that can affect how some NAD+ precursor formulations are absorbed, depending on the coating and matrix. If you’ve wondered whether crushing changes the outcome, we’ve walked through that question directly in our guide to crushing longevity chews. The tradeoff here wasn’t dangerous, but it likely wasted three weeks of a product that might have worked fine taken whole, at the labeled dose, once daily.

An edge case that changes the calculus

Body weight alone can mislead you. A lean, athletic 70 lb dog and a soft, underconditioned 70 lb dog are not the same patient, even though the label would put them in the same tier. I’ve seen a 70 lb, 11-year-old senior with a body condition score of 8/9 where the honest first move wasn’t an NAD+ chew at all — it was a weight-loss plan, because excess adiposity itself burdens joints and metabolic health more than a cellular-support supplement can offset. Adding NR to that dog before addressing body condition is treating the wrong variable first. Weight-based dosing tables assume a reasonably fit dog; they don’t correct for a heavy-bodied senior who needs the fundamentals addressed before a longevity supplement earns its place in the routine.

For the budget-conscious owner comparing subscription options once you’ve settled on a product, the actual monthly cost for a large dog varies more than most sites admit — we’ve broken that down separately in our NAD+ chew subscription cost guide. And if immune support is part of the goal alongside cellular aging, it’s worth reading how those two categories overlap and where they diverge in our guide to senior dog immune supplements.

Bottom line

Follow the label’s weight-tier dose for a NASC-audited NR product, verify the milligram amount rather than trusting a brand’s framing, and don’t let a supplement decision skip the hands-on exam that tells you whether mobility complaints are cellular, orthopedic, or both. The evidence supports NR as reasonable structure-and-function support for cellular energy in an older dog; it does not support treating any single milligram figure as a validated, dog-specific dose.